Table 2 Laboratory findings on admission and presence of the comorbidities in the study population by ESRD status

WBC count, × 10⁹ per L,

9.4 (6.5–14.0)

8.1 (5.6–11.1)

0.058

Lymphocyte count,× 10⁹/L

1.51(0.98–2.23)

2.00 (1.21–2.80)

0.065

Neutrophils, ×10⁹/L

7.9 (7.06–8.8)

7.3 (6.3–8.1)

0.005

Hb, g/dL

11.8 (9.4–13.7)

13.1 (11.8–14.6)

0.008

RBC, million/mm3

3.87 (3.16–4.55)

4.63 (4.25–5.16)

< 0.001

Platelet counts, ×10³/Ml

188.5(139.5-240.5)

213.0 (165.0-264.5)

0.224

AST, U/L

32 (22–51)

34 (25–49)

0.897

ALT, U/L

27 (18–37)

26 (18–44)

0.569

Creatinine, mg/dl

6.1 (4.5–8.4)

1.0 (0.8–1.3)

< 0.001

PT, s

14.0 (13.5–16.0)

13.5 (13.0–14.0)

0.004

ESR, mm/h

54.0 (26.0-74.5)

35.5 (19.0–64.0)

< 0.009

CRP, mg/l

25.0 (4.0–75.0)

15.7 (3.1–61.5)

0.047

LDH, U/L

461 (374–732)

405 (329–549)

0.226

CPK, U/L

76.0 (45.0-237.0)

73.5 (14.3–135.7)

0.802

Sodium (Na), mmol/L

135 (130–139)

136 (133–138)

0.265

Potassium (K), mmol/L

5.0 (4.4–5.3)

4.2 (3.9–4.5)

< 0.001